Profil bibliographique

Qianguo Mao

Informations fournies par OpenAlex. Research Africa ne déduit ni nationalité, ni poste, ni coordonnées personnelles.

32Publications signalées

234Citations signalées

1Affiliations récentes

Institutions déclarées

Domaines associés

Hepatitis B Virus StudiesHepatitis C virus researchLiver Disease Diagnosis and TreatmentHepatitis Viruses Studies and EpidemiologyImmunotherapy and Immune Responses

Publications récentes

Accès ouvert 2025 articleOpenAlex

Comparative efficacy and safety of pegylated interferon-alpha monotherapy vs combination therapies with entecavir or tenofovir in chronic hepatitis B patients

Huiqing Liang, Xiaoting Zheng, Qianguo Mao, Jiaen Yang et autres

5 citationsMicrobiology Spectrum

2025 articleOpenAlex

Effects of Different Antiviral Treatments on Liver Inflammation and Fibrosis in Patients With Chronic Hepatitis B

Xiaoting Zheng, Yaoyu Liu, Qianguo Mao, Chuncheng Wu et autres

2 citationsJournal of Viral Hepatitis

2024 articleOpenAlex

A randomized phase 2b study of subcutaneous PD-L1 antibody ASC22 in virally suppressed patients with chronic hepatitis B who are HBeAg-negative

Jiandan Qian, Yao Xie, Qianguo Mao, Qing Xie et autres

29 citationsHepatology

2023 articleOpenAlex

A phase 2 study of ASC42, a novel farnesoid X receptor (FXR) agonist, in combination with PEGylated interferon (PEG-IFN) and entecavir(ETV) in chronic hepatitis B patients with 12-week treatment

Jinlin Hou, Qianguo Mao, Jing Yuan, Gengwang Hu et autres

0 citationsJournal of Hepatology

2022 articleOpenAlex

ALT flares were linked to HBsAg reduction, seroclearance and seroconversion: interim results from a phase IIb study in chronic hepatitis B patients with 24-week treatment of subcutaneous PD-L1 Ab ASC22 (Envafolimab) plus nucleos (t)ide analogs

Guiqiang Wang, Yimin Cui, Yao Xie, Qianguo Mao et autres

20 citationsJournal of Hepatology

Accès ouvert 2021 articleOpenAlex

Pradefovir Treatment in Patients With Chronic Hepatitis B: Week 24 Results From a Multicenter, Double-Blind, Randomized, Noninferiority, Phase 2 Trial

Yanhang Gao, Fei Kong, Xinwen Song, Jia Shang et autres

16 citationsClinical Infectious Diseases

2021 articleOpenAlex

Comparison of Interferon-α-based therapy and nucleos(t)ide analogs in preventing adverse outcomes in patients with chronic hepatitis B

Qianguo Mao, Huiqing Liang, Yalin Yin, Jinmo Tang et autres

9 citationsClinics and Research in Hepatology and Gastroenterology

Accès ouvert 2020 articleOpenAlex

Pradefovir in naive or experienced adult patients with chronic infection of hepatitis B virus: week24 results from 23 multicentre, double-blind, randomised, non-inferiority, phase2 trials

Yanhang Gao, Fei Kong, Guangming Li, Qianguo Mao et autres

0 citationsJournal of Hepatology

Accès ouvert 2020 articleOpenAlex

Impact of Hepatic Steatosis on the Antiviral Effects of PEG-IFNα-2a in Patients with Chronic Hepatitis B and the Associated Mechanism

Huiqing Liang, Yaoyu Liu, Xiaoqian Jiang, Xiaoting Zheng et autres

7 citationsGastroenterology Research and Practice

Accès ouvert 2019 articleOpenAlex

Predictive value of plasmacytoid dendritic cells and Toll‑like receptor‑9 regarding the treatment efficacy of interferon‑α in HBeAg‑positive chronic hepatitis B patients

Yue Chen, Jiaen Yang, Jing‐Mo Tang, Qianguo Mao et autres

14 citationsExperimental and Therapeutic Medicine

Accès ouvert 2019 articleOpenAlex

A Potential Functional Cure in Chinese HBeAg-negative Chronic Hepatitis B Patients Treated with Peg-interferon Alpha-2a

Xinyue Chen, Qianguo Mao, Yao Xie, Xiaoguang Dou et autres

9 citationsJournal of Clinical and Translational Hepatology

2019 articleOpenAlex

Transcriptional response of USP18 predicts treatment outcomes of interferon‐alpha in HBeAg‐positive chronic hepatitis B patientsefere

Wei Liu, Huiqing Liang, Shaojuan Wang, Chuncheng Wu et autres

2 citationsJournal of Viral Hepatitis

Notice OpenAlex

BNTIC News n’est pas le producteur de ces données. Recherche à la demande dans Crossref, OpenAIRE, DOAJ, Europe PMC, HAL, DataCite, ROR et la Banque mondiale, sans clé ; OpenAlex reste optionnel. Aucun service payant requis, aucune donnée externe enregistrée en base. Sources et limites.